SCHEMBL7087322

SCHEMBL7087322

O=C1COCc2ccccc2N1CCN1CCN(c2nccc3ccccc23)CC1

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.51
HTR1A P08908 4/20 0.50
HTR1B P28222 2/20 0.50
HTR1D P28221 1/20 0.50
SLC6A4 P31645 1/20 0.50
HTR7 P34969 2/20 0.48
DRD2 P14416 2/20 0.44
HTR2A P28223 1/20 0.44
MCHR1 Q99705 1/20 0.44
DRD4 P21917 1/20 0.44
DRD3 P35462 1/20 0.44
ADRA1D P25100 1/20 0.43
ADRA1A P35348 1/20 0.43
ADRA1B P35368 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6715832 0.88 HTR1A (0.63) HRH4HTR1AHTR1BHTR1DSLC6A4
SCHEMBL6973851 0.87 DRD2 (0.59) HRH4HTR1AHTR1BHTR1DSLC6A4
SCHEMBL6711688 0.87 HRH4 (0.52) HRH4HTR1AHTR1BHTR1DSLC6A4
SCHEMBL6715989 0.87 DRD2 (0.59) HRH4HTR1AHTR7DRD2DRD4
Hydrochloric Acid SCHEMBL6711485 0.85 DRD2 (0.57) HRH4HTR1AHTR1BHTR1DSLC6A4
SCHEMBL7084667 0.84 HRH4 (0.51) HRH4HTR1AHTR1BHTR1DSLC6A4
SCHEMBL7082418 0.81 DRD2 (0.65) HTR1AHTR1BHTR1DSLC6A4HTR7
SCHEMBL6978625 0.81 GRIN1 (0.58) HRH4HTR1AHTR7DRD2DRD4
SCHEMBL6977709 0.81 GRIN1 (0.66) HTR1AHTR7DRD2DRD4DRD3
SCHEMBL6714648 0.79 HTR1A (0.49) HRH4HTR1AHTR1BHTR1DSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296954-A1 BICYCLIC LACTAMS AND SULFONAMIDES WITH 5-HT1A-AFFINITY AND USE THEREOF FOR PREVENTING AND TREATING CEREBRAL ISCHAEMIA Abbott GmbH & Co. KG (DE) 2003-04-02 EP disclosed
WO-2002002529-A1 BICYCLIC LACTAMS AND SULFONAMIDES WITH 5-HT1A-AFFINITY AND USE THEREOF FOR PREVENTING AND TREATING CEREBRAL ISCHAEMIA ABBOTT GMBH & CO. KG (DE) 2002-01-10 WO disclosed